Form 4: Omada Health Director Acquires Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Jeryl L. Hilleman, a Director at Omada Health, Inc., acquired 1,299 restricted stock units (RSUs) on July 5, 2026, as part of the company's Non-Employee Director Compensation Program.

Summary

  • Jeryl L. Hilleman, a Director at Omada Health, Inc. (OMDA), acquired 1,299 restricted stock units (RSUs) on July 5, 2026.
  • These RSUs were granted under the company's Non-Employee Director Compensation Program in lieu of retainer fees.
  • Each RSU represents the right to receive one share of Common Stock.
  • Settlement of the RSUs will occur on a date selected by the Reporting Person or as otherwise provided by the Program.
  • Following this transaction, Hilleman beneficially owns 26,519 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director compensation transaction rather than a significant strategic or financial event.

Positives

  • Director Hilleman's acquisition of RSUs indicates continued commitment and alignment with the company's performance.
  • The acquisition is part of a structured compensation program, suggesting a predictable and transparent incentive mechanism for directors.

Future Outlook

The future settlement of RSUs is dependent on the terms of the Non-Employee Director Compensation Program and the reporting person's selection of a settlement date.

Industry Context

StockSavvy.ai notes that the issuance of RSUs to non-employee directors is a common practice in the healthcare technology sector, aligning director incentives with long-term shareholder value.

Related Party Transactions

  • The acquisition of RSUs by Director Jeryl L. Hilleman is part of the company's Non-Employee Director Compensation Program, which is a standard related party transaction for compensation purposes.

Stakeholder Impact

  • Shareholders: The transaction reflects a standard compensation practice and does not immediately impact share count or dilution, but indicates director participation in equity.

Next Steps

  • Settlement of the acquired RSUs at a future date as per the program's terms.

Key Dates

DateDescription
07/05/2026Transaction Date for acquisition of RSUs.
07/07/2026Date of signature for the filing.

Keywords

Omada Health, OMDA, Form 4, SEC Filing, Director Compensation, Restricted Stock Units, RSUs, Beneficial Ownership, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.